How to cite this paper
APA: Joshi, K., Dhalani, J., Bhatt, H & Kapadiya, K. (2021). Synthesis of some new 6-aryl-3-(4-isopropylphenyl)[1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles and its anti-microbial study. Current Chemistry Letters, 10(4), 479-488.
Chicago/Turabian: Joshi, K., Dhalani, J., Bhatt, H & Kapadiya, K. 2021. "Synthesis of some new 6-aryl-3-(4-isopropylphenyl)[1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles and its anti-microbial study." Current Chemistry Letters 10, no. 4 (2021): 479-488.
AMA: Joshi, K., Dhalani, J., Bhatt, H & Kapadiya, K. Synthesis of some new 6-aryl-3-(4-isopropylphenyl)[1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles and its anti-microbial study. Current Chemistry Letters. 2021;10(4):479-488.
References
1. Kerru N., Gummidi L., Maddila S., Gangu K., Jonnalagadda S. (2020) A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules, 25 (8) 1909-1950.
2. Gomtsyan A. (2012) Heterocycles in drugs and drug discovery. Chem Heterocycl Comp, 48, 7-10.
3. Martins P., Jesus J., Santos S., Raposo L., Roma-Rodrigues C., Baptista P., Fernandes A. (2015) Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box. Molecules, 20 (9) 16852-16891.
4. Jhaa A., Prasad K., Kulkarni A. (2009) Plant system: Nature's nano factory. Colloids and Surfaces B. Biointerfaces., 73 (2) 219-223.
5. Georgios C., Dimitris T., Panagiotis D., Constantinos P., Vasiliki S., Panagiotis Z., Charalambos C. (2019) Synthesis and anti-cancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Arab. J. Chem., 12 (8) 4784-4794.
6. Abdelrazek F., Gomha S., Abdel‐aziz H., Farghaly M., Metz P., Abdel‐Shafy A. (2020) Efficient synthesis and In Silico study of some novel pyrido[2,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine derivatives, J. Heterocycl. Chem., 57 (4) 1759-1769.
7. Gomha S., Edress M., Muhammad Z., Gaber H., Amin M., Matar I. (2019) Synthesis Under Microwave Irradiation and Molecular Docking of Some Novel Bioactive Thiadiazoles. Mini-Rev. Med. Chem., 19 (5) 437-447.
8. Roberta J. (2017) Melander and Christian Melander, The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?. ACS Infectious Diseases, 3 (8) 559-563.
9. Reder-Christ K., Bendas G. (2011) Biosensor Applications in the Field of Antibiotic Research—A Review of Recent Developments. Sensors, 11, 9450–9466.
10. Projan S., Shlaes D. (2004) Antibacterial drug discovery: Is it all downhill from here? Clin. Microbiol. Infect., 10, 18-22.
11. Annunziato G. (2019) Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review. Int. J. Mol. Sci., 20 (23) 5844.
12. Varvaresou A., Tsantili-Kakoulidou A., Siatra-Papastaikoudi T., Tiligada E. (2000) Synthesis and biological evaluation of indole containing derivatives of thiosemicarbazide and their cyclic 1,2,4-triazole and 1,3,4-thiadiazole analogs. Arzneimittel-Forschung., 50 (1) 48-54.
13. Prasad M., Lakshmi C., Katari N., Pal M. (2020) Lemon Juice as a Biocatalyst Under Ultrasound Irradiation: Synthesis and Pharmacological Evaluation of 2-amino 1,3,4-thiadiazoles. Anti-cancer Agents Med Chem., 20 (11) 1379-1386.
14. Alminderej F., Elganzory H., El-Bayaa M., Awad H., El-Sayed W. (2019) Synthesis and Cytotoxic Activity of New 1,3,4-Thiadiazole Thioglycosides and 1,2,3-Triazolyl-1,3,4-Thiadiazole N-glycosides. Molecules, 24 (20) 3738.
15. Hu, Y., Li, C., Wang, X., Yang, Y., Zhu, H. (2014) 1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry, Chem. Rev., 114 (10) 5572-5610.
16. Lidia L., Eliezer B. (2005) Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design. Curr. Med. Chem., 12, 23-49.
17. Serban G., Stanasel O., Serban E., Bota S. (2018) 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising anti-microbial agents. Drug Des Devel Ther., 12, 1545-1566.
18. Serban G. (2020) Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections. Molecules, 25 (4) 942.
19. Liu Y., Zhang Y., Zhang J., Hu L., Han S. (2020) A copper-catalyzed approach for the synthesis of asymmetrical disubstituted 1,2,4-thiadiazoles via elemental sulfur-mediated decarboxylative redox cyclization. Tetrahedron Lett., 65, 152744.
20. Jain A., Sharma S., Vaidya A., Veerasamy R., Agrawal R. (2013) 1,3,4-Thiadiazole and Its Derivatives: A Review on Recent Progress in Biological Activities. Chem Biol Drug Des., 81 (5) 557-576.
21. Al-Masoudi I., Al-Soud Y., Al-Salihi N., Al-Masoudi N. (2006) 1,2,4-triazoles: synthetic approaches and pharmacological importance. Chem Heterocycl Compd., 42 (11) 1377–1403.
22. Maertens A. (2004) History of the development of azole derivatives. Clin Microbiol Infect., 10 (1) 1–10.
23. Morigi R., Locatelli A., Leoni A., Rambaldi M. (2015) Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity. Anticancer Drug Discov., 10 (3) 280-297.
24. Karabasanagouda Adhikari A., Shetty N. (2007) Synthesis and anti-microbial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties. Eur. J. Med. Chem., 42 (4) 521-529.
25. Bhalla M., Hitkari A., Gujrati V., Bhalla T., Shanker K. (1994) Benzopyran-2-one derivatives: antiinflammatory, analgesic and antiproteolytic agent. Eur. J. Med. Chem., 29 (9) 713-717.
26. Kritsanida M., Mouroutsou A., Marakos P., Pouli N., Papakonstantinou-Garoufalias S., Pannecouque C., Witvrouw M., De Clercq E. (2002) Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. Farmaco, 57 253-257.
27. Chawla G., Kumar U., Bawa S., Kumar J. (2011) Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J Enzyme Inhib Med Chem., 27 658-65.
28. Chowrasia D., Karthikeyan C., Choure L., Sahabjada Gupta M., Arshad M., Trivedi P. (2017) Synthesis, characterization and anti-cancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab. J. Chem., 10 (2) S2424-S2428.
29. Zhang L., Zhao J., Zhang B., Lu T., Chen Y. (2018) Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem., 150 809-816.
30. Pandit C., Pandya M., Jadeja Y., Gohel J., Kapadiya K. (2020) An efficient regioselective synthesis of N-alkylated purine-triazole analogues. Ind. J. Chem. Sect. B., 59B (8) 1225-1233.
31. Kapadiya K., Jadeja Y., Khunt R. (2018) Synthesis of Purine based Triazoles by Copper (I)-Catalyzed Huisgen Azide-Alkyne Cycloaddition Reaction. J. Heterocycl. Chem., 55 (1) 199–208.
32. Wanja D., Mbuthia P., Robert M., Waruiru R., Bebora L., Ngowi H., Nyaga P. (2020) Antibiotic and Disinfectant Susceptibility Patterns of Bacteria Isolated from Farmed Fish in Kirinyaga County, Kenya. Int. J. Microbiol., 2020 8897338 8 pages.
33. Missaoui J., Saidane D., Mzoughi R., Minervini F. (2019) Fermented Seeds ("Zgougou") from Aleppo Pine as a Novel Source of Potentially Probiotic Lactic Acid Bacteria. Microorganisms, 7 (12) 709-731.
34. Nussbaumer-Pröll A., Knotzer S., Eberl S. (2019) Impact of erythrocytes on bacterial growth and anti-microbial activity of selected antibiotics. Eur J Clin Microbiol Infect Dis., 38 (3) 485-495.
1. Kerru N., Gummidi L., Maddila S., Gangu K., Jonnalagadda S. (2020) A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules, 25 (8) 1909-1950.
2. Gomtsyan A. (2012) Heterocycles in drugs and drug discovery. Chem Heterocycl Comp, 48, 7-10.
3. Martins P., Jesus J., Santos S., Raposo L., Roma-Rodrigues C., Baptista P., Fernandes A. (2015) Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box. Molecules, 20 (9) 16852-16891.
4. Jhaa A., Prasad K., Kulkarni A. (2009) Plant system: Nature's nano factory. Colloids and Surfaces B. Biointerfaces., 73 (2) 219-223.
5. Georgios C., Dimitris T., Panagiotis D., Constantinos P., Vasiliki S., Panagiotis Z., Charalambos C. (2019) Synthesis and anti-cancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Arab. J. Chem., 12 (8) 4784-4794.
6. Abdelrazek F., Gomha S., Abdel‐aziz H., Farghaly M., Metz P., Abdel‐Shafy A. (2020) Efficient synthesis and In Silico study of some novel pyrido[2,3‐d][1,2,4]triazolo[4,3‐a]pyrimidine derivatives, J. Heterocycl. Chem., 57 (4) 1759-1769.
7. Gomha S., Edress M., Muhammad Z., Gaber H., Amin M., Matar I. (2019) Synthesis Under Microwave Irradiation and Molecular Docking of Some Novel Bioactive Thiadiazoles. Mini-Rev. Med. Chem., 19 (5) 437-447.
8. Roberta J. (2017) Melander and Christian Melander, The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?. ACS Infectious Diseases, 3 (8) 559-563.
9. Reder-Christ K., Bendas G. (2011) Biosensor Applications in the Field of Antibiotic Research—A Review of Recent Developments. Sensors, 11, 9450–9466.
10. Projan S., Shlaes D. (2004) Antibacterial drug discovery: Is it all downhill from here? Clin. Microbiol. Infect., 10, 18-22.
11. Annunziato G. (2019) Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review. Int. J. Mol. Sci., 20 (23) 5844.
12. Varvaresou A., Tsantili-Kakoulidou A., Siatra-Papastaikoudi T., Tiligada E. (2000) Synthesis and biological evaluation of indole containing derivatives of thiosemicarbazide and their cyclic 1,2,4-triazole and 1,3,4-thiadiazole analogs. Arzneimittel-Forschung., 50 (1) 48-54.
13. Prasad M., Lakshmi C., Katari N., Pal M. (2020) Lemon Juice as a Biocatalyst Under Ultrasound Irradiation: Synthesis and Pharmacological Evaluation of 2-amino 1,3,4-thiadiazoles. Anti-cancer Agents Med Chem., 20 (11) 1379-1386.
14. Alminderej F., Elganzory H., El-Bayaa M., Awad H., El-Sayed W. (2019) Synthesis and Cytotoxic Activity of New 1,3,4-Thiadiazole Thioglycosides and 1,2,3-Triazolyl-1,3,4-Thiadiazole N-glycosides. Molecules, 24 (20) 3738.
15. Hu, Y., Li, C., Wang, X., Yang, Y., Zhu, H. (2014) 1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry, Chem. Rev., 114 (10) 5572-5610.
16. Lidia L., Eliezer B. (2005) Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design. Curr. Med. Chem., 12, 23-49.
17. Serban G., Stanasel O., Serban E., Bota S. (2018) 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising anti-microbial agents. Drug Des Devel Ther., 12, 1545-1566.
18. Serban G. (2020) Synthetic Compounds with 2-Amino-1,3,4-Thiadiazole Moiety Against Viral Infections. Molecules, 25 (4) 942.
19. Liu Y., Zhang Y., Zhang J., Hu L., Han S. (2020) A copper-catalyzed approach for the synthesis of asymmetrical disubstituted 1,2,4-thiadiazoles via elemental sulfur-mediated decarboxylative redox cyclization. Tetrahedron Lett., 65, 152744.
20. Jain A., Sharma S., Vaidya A., Veerasamy R., Agrawal R. (2013) 1,3,4-Thiadiazole and Its Derivatives: A Review on Recent Progress in Biological Activities. Chem Biol Drug Des., 81 (5) 557-576.
21. Al-Masoudi I., Al-Soud Y., Al-Salihi N., Al-Masoudi N. (2006) 1,2,4-triazoles: synthetic approaches and pharmacological importance. Chem Heterocycl Compd., 42 (11) 1377–1403.
22. Maertens A. (2004) History of the development of azole derivatives. Clin Microbiol Infect., 10 (1) 1–10.
23. Morigi R., Locatelli A., Leoni A., Rambaldi M. (2015) Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity. Anticancer Drug Discov., 10 (3) 280-297.
24. Karabasanagouda Adhikari A., Shetty N. (2007) Synthesis and anti-microbial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties. Eur. J. Med. Chem., 42 (4) 521-529.
25. Bhalla M., Hitkari A., Gujrati V., Bhalla T., Shanker K. (1994) Benzopyran-2-one derivatives: antiinflammatory, analgesic and antiproteolytic agent. Eur. J. Med. Chem., 29 (9) 713-717.
26. Kritsanida M., Mouroutsou A., Marakos P., Pouli N., Papakonstantinou-Garoufalias S., Pannecouque C., Witvrouw M., De Clercq E. (2002) Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. Farmaco, 57 253-257.
27. Chawla G., Kumar U., Bawa S., Kumar J. (2011) Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J Enzyme Inhib Med Chem., 27 658-65.
28. Chowrasia D., Karthikeyan C., Choure L., Sahabjada Gupta M., Arshad M., Trivedi P. (2017) Synthesis, characterization and anti-cancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab. J. Chem., 10 (2) S2424-S2428.
29. Zhang L., Zhao J., Zhang B., Lu T., Chen Y. (2018) Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem., 150 809-816.
30. Pandit C., Pandya M., Jadeja Y., Gohel J., Kapadiya K. (2020) An efficient regioselective synthesis of N-alkylated purine-triazole analogues. Ind. J. Chem. Sect. B., 59B (8) 1225-1233.
31. Kapadiya K., Jadeja Y., Khunt R. (2018) Synthesis of Purine based Triazoles by Copper (I)-Catalyzed Huisgen Azide-Alkyne Cycloaddition Reaction. J. Heterocycl. Chem., 55 (1) 199–208.
32. Wanja D., Mbuthia P., Robert M., Waruiru R., Bebora L., Ngowi H., Nyaga P. (2020) Antibiotic and Disinfectant Susceptibility Patterns of Bacteria Isolated from Farmed Fish in Kirinyaga County, Kenya. Int. J. Microbiol., 2020 8897338 8 pages.
33. Missaoui J., Saidane D., Mzoughi R., Minervini F. (2019) Fermented Seeds ("Zgougou") from Aleppo Pine as a Novel Source of Potentially Probiotic Lactic Acid Bacteria. Microorganisms, 7 (12) 709-731.
34. Nussbaumer-Pröll A., Knotzer S., Eberl S. (2019) Impact of erythrocytes on bacterial growth and anti-microbial activity of selected antibiotics. Eur J Clin Microbiol Infect Dis., 38 (3) 485-495.